- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 31, 2025 | 211.78M sh |
| Shares Outstanding | Q1 2024 · Dec 31, 2024 | 213.3M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2025 | $252.14M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2024 | $232.14M |
| Current Liabilities | Q1 2024 · Mar 31, 2025 | $170.97M |
| Current Liabilities | Q1 2024 · Dec 31, 2024 | $203.37M |
| Total Liabilities | Q1 2024 · Mar 31, 2025 | $191.48M |
| Total Liabilities | Q1 2024 · Dec 31, 2024 | $226.27M |
| Current Assets | Q1 2024 · Mar 31, 2025 | $561.23M |
| Current Assets | Q1 2024 · Dec 31, 2024 | $580.21M |
| Total Assets | Q1 2024 · Mar 31, 2025 | $681.65M |
| Total Assets | Q1 2024 · Dec 31, 2024 | $693.04M |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 216.87M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2024 | $10.8M |
| Dividends Paid | Q1 2024 · Mar 31, 2024 | $1.44M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | $56.69M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $552.57M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $534.87M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.09 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.09 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $18.51M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $14.85M |
| Net Income | Q1 2024 · Mar 31, 2024 | $19.65M |
| Operating Income | Q1 2024 · Mar 31, 2024 | $25.21M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $91.59M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $75.8M |
| Revenue | Q1 2024 · Mar 31, 2024 | $167.39M |